CTVA.NYSECorteva, INC

Form 4: Corteva Executive Brian Titus Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Brian Titus, a Corteva executive, reported the acquisition and disposal of company stock and stock options on February 18, 2025.

Summary

  • On February 18, 2025, Brian Titus, VP, Controller and Principal Accounting Officer of Corteva, Inc., reported transactions involving Corteva's common stock and non-qualified stock options.
  • Titus disposed of 132 shares of common stock to cover tax obligations at a price of $64.46 per share.
  • He also acquired 1,009 shares of common stock.
  • Following these transactions, Titus beneficially owns 16,473.3047 shares of Corteva common stock.
  • Additionally, Titus acquired 2,730 non-qualified stock options with an exercise price of $64.46, vesting in three equal annual installments beginning February 18, 2026, and expiring on February 18, 2035.
  • After the transaction, Titus holds 2,730 derivative securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document is a standard regulatory filing reporting stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Positives

  • The acquisition of 1,009 shares by a company executive could be seen as a positive signal.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

  • Executive compensation packages, including stock options, are common in publicly traded companies like Corteva to align management's interests with those of shareholders.
  • The vesting schedule of the options (three equal annual installments) is a standard practice.
  • Comparable companies in the agricultural sector, such as Bayer and Syngenta, also utilize stock options as part of their executive compensation plans.

Stakeholder Impact

  • Shareholders may be interested in the trading activity of company insiders as an indicator of management's view of the company's value.

Key Dates

DateDescription
02/18/2025Date of stock and stock option transactions.
02/18/2026First vesting date for the non-qualified stock options.
02/18/2035Expiration date for the non-qualified stock options.
02/20/2025Date of signature on the Form 4 filing.

Keywords

Corteva, Stock Options, Stock Transactions, Form 4, Executive Compensation, Brian Titus

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.